Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Pyenson

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
American Health & Drug Benefits|July 4, 2014
National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costsBetsy J Lahue, Bruce Pyenson, Kosuke Iwasaki, et al.
Journal of Health Economics and Outcomes Research|February 6, 2023
PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD PopulationGerard Criner, Fernando Martinez, Hitesh Gandhi, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Applying Machine Learning Techniques to Identify Undiagnosed Patients with Exocrine Pancreatic InsufficiencyBruce Pyenson, Maggie Alston, Jeffrey Gomberg, et al.
Journal of Health Economics and Outcomes Research|November 18, 2024
We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?Rebecca Smith, Samara Eisenberg, Aaron Turner-Pfifer, et al.
Journal of Health Economics and Outcomes Research|April 21, 2025
Erratum: Article Correction: We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?Rebecca Smith, Samara Eisenberg, Aaron Turner-Phifer, et al.
JTO Clinical and Research Reports|December 24, 2025
First Central Asian Forum on Lung CancerJandos Amankulov, David F Yankelevitz, Amangeldi Mukhamejan, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|March 30, 2026
Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS CanadaMohit Bhutani, Alan Kaplan, Sheena Kayaniyil, et al.
JTO Clinical and Research Reports|March 19, 2026
Corrigendum to 'First Central Asian Forum on Lung Cancer' [JTO Clinical and Research Reports Volume 7 Issue 1 (2026) 100898]Jandos Amankulov, David F Yankelevitz, Amangeldi Mukhamejan, et al.
Journal of Managed Care & Specialty Pharmacy|June 25, 2019
Prevalence, Patterns, and Cost of Care for Children with Cerebral Palsy Enrolled in Medicaid Managed CareSonia Pulgar, Savreet Bains, Judith Gooch, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impactsMaarten J Postma, George Milne, E Anthony S Nelson, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
American Health & Drug Benefits|July 4, 2014
National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costsBetsy J Lahue, Bruce Pyenson, Kosuke Iwasaki, et al.
Journal of Health Economics and Outcomes Research|February 6, 2023
PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD PopulationGerard Criner, Fernando Martinez, Hitesh Gandhi, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Applying Machine Learning Techniques to Identify Undiagnosed Patients with Exocrine Pancreatic InsufficiencyBruce Pyenson, Maggie Alston, Jeffrey Gomberg, et al.
Journal of Health Economics and Outcomes Research|November 18, 2024
We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?Rebecca Smith, Samara Eisenberg, Aaron Turner-Pfifer, et al.
Journal of Health Economics and Outcomes Research|April 21, 2025
Erratum: Article Correction: We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?Rebecca Smith, Samara Eisenberg, Aaron Turner-Phifer, et al.
JTO Clinical and Research Reports|December 24, 2025
First Central Asian Forum on Lung CancerJandos Amankulov, David F Yankelevitz, Amangeldi Mukhamejan, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|March 30, 2026
Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS CanadaMohit Bhutani, Alan Kaplan, Sheena Kayaniyil, et al.
JTO Clinical and Research Reports|March 19, 2026
Corrigendum to 'First Central Asian Forum on Lung Cancer' [JTO Clinical and Research Reports Volume 7 Issue 1 (2026) 100898]Jandos Amankulov, David F Yankelevitz, Amangeldi Mukhamejan, et al.
Journal of Managed Care & Specialty Pharmacy|June 25, 2019
Prevalence, Patterns, and Cost of Care for Children with Cerebral Palsy Enrolled in Medicaid Managed CareSonia Pulgar, Savreet Bains, Judith Gooch, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impactsMaarten J Postma, George Milne, E Anthony S Nelson, et al.
Pageof 5